Last updated 8 months ago
Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma
291 patients around the world
Available in Spain, Chile, Brazil, Argentina, United States
Exelixis
4Research sites
291Patients around the world
This study is for people with
Kidney cancer
Renal cell carcinoma
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Instituto de Investigaciones Clínicas Mar del Plata
Recruiting
Centro de Investigaciones Clínicas - Clínica Viedma - Río Negro
Recruiting
Hospital Universitario Austral - Pilar
Recruiting
Instituto Médico de la Fundación Estudios Clínicos - Rosario
Recruiting
StudySTELLAR-304
SponsorExelixis
Conditions
Renal cell carcinomaKidney cancer
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT05678673
